Thrivent Financial for Lutherans Reduces Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Thrivent Financial for Lutherans cut its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 64.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 45,742 shares of the medical instruments supplier’s stock after selling 83,371 shares during the quarter. Thrivent Financial for Lutherans’ holdings in DENTSPLY SIRONA were worth $1,457,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in XRAY. John G Ullman & Associates Inc. raised its position in DENTSPLY SIRONA by 0.8% during the fourth quarter. John G Ullman & Associates Inc. now owns 130,510 shares of the medical instruments supplier’s stock worth $4,155,000 after acquiring an additional 1,055 shares during the last quarter. Nordea Investment Management AB lifted its stake in DENTSPLY SIRONA by 37.1% in the 4th quarter. Nordea Investment Management AB now owns 537,553 shares of the medical instruments supplier’s stock valued at $17,207,000 after buying an additional 145,549 shares in the last quarter. Desjardins Global Asset Management Inc. grew its holdings in DENTSPLY SIRONA by 12.5% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 6,536 shares of the medical instruments supplier’s stock valued at $208,000 after buying an additional 728 shares during the last quarter. Russell Investments Group Ltd. increased its position in DENTSPLY SIRONA by 22.5% during the fourth quarter. Russell Investments Group Ltd. now owns 961,463 shares of the medical instruments supplier’s stock worth $30,622,000 after buying an additional 176,834 shares in the last quarter. Finally, Nuance Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 0.7% in the fourth quarter. Nuance Investments LLC now owns 12,642,319 shares of the medical instruments supplier’s stock worth $402,531,000 after acquiring an additional 92,591 shares during the last quarter. 98.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on XRAY shares. Stifel Nicolaus boosted their target price on shares of DENTSPLY SIRONA from $37.00 to $41.00 in a research note on Thursday, May 4th. UBS Group upped their price objective on shares of DENTSPLY SIRONA from $43.00 to $46.00 in a research note on Friday, May 5th. Robert W. Baird lifted their target price on shares of DENTSPLY SIRONA from $36.00 to $46.00 in a research note on Thursday, May 4th. Piper Sandler increased their price target on DENTSPLY SIRONA from $29.00 to $35.00 and gave the stock a “neutral” rating in a research note on Monday, February 6th. Finally, Morgan Stanley lifted their price objective on DENTSPLY SIRONA from $39.00 to $45.00 and gave the company an “overweight” rating in a research report on Wednesday, April 19th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $42.13.

DENTSPLY SIRONA Stock Down 0.8 %

Shares of XRAY opened at $40.19 on Monday. The firm has a market cap of $8.54 billion, a PE ratio of 15.05, a price-to-earnings-growth ratio of 2.30 and a beta of 0.91. The company has a quick ratio of 0.93, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The company’s fifty day moving average is $39.76 and its two-hundred day moving average is $35.85. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its earnings results on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.05. The firm had revenue of $978.00 million for the quarter, compared to analysts’ expectations of $938.16 million. DENTSPLY SIRONA had a positive return on equity of 8.65% and a negative net margin of 26.41%. The firm’s revenue for the quarter was up .9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.52 earnings per share. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.91 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 14th. Investors of record on Friday, March 31st were issued a $0.125 dividend. The ex-dividend date of this dividend was Thursday, March 30th. This represents a $0.50 annualized dividend and a yield of 1.24%.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, SVP Cord Friedrich Staehler sold 4,000 shares of the firm’s stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total value of $157,320.00. Following the transaction, the senior vice president now owns 97,693 shares of the company’s stock, valued at approximately $3,842,265.69. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,200 shares of the company’s stock in a transaction that occurred on Tuesday, May 2nd. The stock was sold at an average price of $42.17, for a total value of $261,454.00. Following the completion of the transaction, the director now owns 44,902 shares in the company, valued at approximately $1,893,517.34. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Cord Friedrich Staehler sold 4,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total transaction of $157,320.00. Following the sale, the senior vice president now owns 97,693 shares in the company, valued at approximately $3,842,265.69. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Profile

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.